Brain Metastases From Esophageal Cancer: A Phenomenon of Adjuvant Therapy?

Annals of Thoracic Surgery

Volumn 82, Issue 6, 2006, Pages

  Rice, Thomas W ^a   Khuntia, Deepak ^a   Rybicki, Lisa A ^a   Adelstein, David J ^a   Vogelbaum, Michael A ^a   Mason, David P ^a   Murthy, Sudish C ^a   Blackstone, Eugene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HAZARD ASSESSMENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME;

EID: 33751199359     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.06.089     Document Type: Article

References (24)

1. Adelstein D.J., Rice T.W., Becker M., et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 80 (1997) 1011-1020
2. Adelstein D.J., Rice T.W., Rybicki L.A., et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer?. A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 18 (2000) 2032-2039
3. Rice T.W., Adelstein D.J., Chidel M.A., et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 126 (2003) 1590-1596
4. Khuntia D., Sajja R., Chidel M.A., et al. Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective review. Technol Cancer Res Treat 2 (2003) 267-272
5. Attah E.B., and Hajdu S.I. Benign and malignant tumors of the esophagus at autopsy. J Thorac Cardiovasc Surg 55 (1968) 396-404
6. Anderson L.L., and Lad T.E. Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 50 (1982) 1587-1590
7. Bosch A., Frias Z., Caldwell W.L., and Jaeschke W.H. Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol Radiat Phys Biol 18 (1979) 103-112
8. Sons H.U., and Borchard F. Esophageal cancer. Autopsy findings in 171 cases. Arch Pathol Lab Med 108 (1984) 983-988
9. Chan K.W., Chan E.Y., and Chan C.W. Carcinoma of the esophagus. An autopsy study of 231 cases. Pathology 18 (1986) 400-405
10. Katayama A., Mafune K., Tanaka Y., Takubo K., Makuuchi M., and Kaminishi M. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg 196 (2003) 866-873
11. Mafune K.I., Tanaka Y., and Takubo K. Autopsy findings in patients with esophageal carcinoma: comparison between resection and nonresection groups. J Surg Oncol 74 (2000) 196-200
12. Gabrielsen T.O., Eldevik O.P., Orringer M.B., and Marshall B.L. Esophageal carcinoma metastatic to the brain: clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy. AJNR Am J Neuroradiol 16 (1995) 1915-1921
13. Weinberg J.S., Suki D., Hanbali F., Cohen Z.R., Lenzi R., and Sawaya R. Metastasis of esophageal carcinoma to the brain. Cancer 98 (2003) 1925-1933
14. Ogawa K., Toita T., Sueyama H., et al. Brain metastases from esophageal carcinoma. Cancer 94 (2002) 759-764
15. Blackstone E.H., Naftel D.C., and Turner Jr. M.E. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 81 (1986) 615-624
16. Breiman L. Bagging predictors. Machine Learning 24 (1996) 123-140
17. Blackstone E.H. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 122 (2001) 430-439
18. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
19. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
20. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
21. Mao Y.S., Suntharalingam M., and Krasna M.J. Management of late distant metastases after trimodality therapy for esophageal cancer. Ann Thorac Surg 76 (2003) 1742-1743
22. Murray K.J., Scott C., Greenberg H.M., et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39 (1997) 571-574
23. Nathoo N., Chahlavi A., Barnett G.H., and Toms S.A. Pathobiology of brain metastases. J Clin Pathol 58 (2005) 237-242
24. Marchetti D., Denkins Y., Reiland J., et al. Brain-metastatic melanoma: a neurotrophic perspective. Pathol Oncol Res 9 (2003) 147-158